Darifenacin
Darifenacin is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand name including Darifenacin. Available dosage forms: tablet, film coated, extended release, tablet, extended release.
Drug Details
- Generic Name
- Darifenacin
- Brand Names
- Darifenacin
- Application Number
- ANDA206743
- Sponsor
- Rising Pharma Holdings, Inc.
- NDC Codes
- 10
- Dosage Forms
- TABLET, FILM COATED, EXTENDED RELEASE, TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- DARIFENACIN HYDROBROMIDE
Indications and Usage
1 INDICATIONS AND USAGE Darifenacin is muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Darifenacin extended-release tablets are muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. (1)